11β-Hydroxysteroid Dehydrogenase Type 1 in Obese Subjects With Type 2 Diabetes Mellitus

被引：12
|
作者：
Li, Xia [1 ]
Wang, Jingli [2 ]
Yang, Qin [3 ]
Shao, Shiying [4 ]
机构：
[1] Three Gorges Univ, Peoples Hosp, Peoples Hosp Yichang 1, Div Endocrinol, Yichang, Peoples R China
[2] Jingzhou Cent Hosp, Div Endocrinol, Jingzhou, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Hosp, Div Pathol, Jiefang Rd 1095, Wuhan 430030, Hubei, Peoples R China
[4] Huazhong Univ Sci & Technol, Tongji Hosp, Div Endocrinol, Wuhan, Hubei, Peoples R China
来源：
AMERICAN JOURNAL OF THE MEDICAL SCIENCES | 2017年 / 354卷 / 04期
基金：
中国国家自然科学基金;
关键词：
11 beta-Hydroxysteroid dehydrogenase type 1; Obesity; Type 2 diabetes mellitus; Insulin resistance; INSULIN-RECEPTOR SUBSTRATE-1; SUBCUTANEOUS ADIPOSE-TISSUE; 11-BETA-HSD1; INHIBITION; SELECTIVE-INHIBITION; CORTISOL METABOLISM; GLUCOSE-TOLERANCE; PANCREATIC-ISLETS; BI; 135585; MICE; RESISTANCE;
D O I：
10.1016/j.amjms.2017.03.023
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Obesity is one of the most significant contributors to the development of type 2 diabetes mellitus. Tissue-specific glucocorticoids regulated by 11 beta-hydroxysteroid dehydrogenase enzyme (11 beta-HSD) type 1 are involved in central obesity and obesity-related comorbidities. Moderate downregulation of 11 beta-HSD1 can attenuate insulin insensitivity and the impairment of glucose-stimulated insulin secretion. Some of the beneficial effects of 11 beta-HSD1 inhibition may be mediated, at least in part, through inactivation of tissue-specific glucocorticoid action related to insulin signaling mechanisms, alleviation of abnormal cytokine profile and the improvement of beta-cell function. Thus, 11 beta-HSD1 is a promising target for the treatment and prevention of type 2 diabetes mellitus with obesity.
引用
收藏
页码：408 / 414
页数：7
相关论文
共 50 条
  • [1] 11β-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus
    Valsamakis, G
    Anwar, A
    Tomlinson, JW
    Shackleton, CHL
    McTernan, PG
    Chetty, R
    Wood, PJ
    Banerjee, AK
    Holder, G
    Barnett, AH
    Stewart, PM
    Kumar, S
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09): : 4755 - 4761
  • [2] 11β-Hydroxysteroid dehydrogenase type 1 inhibition in type 2 diabetes mellitus
    Hollis, G.
    Huber, R.
    [J]. DIABETES OBESITY & METABOLISM, 2011, 13 (01): : 1 - 6
  • [3] Type 2 diabetes and metabolic syndrome are associated with increased expression of 11β-hydroxysteroid dehydrogenase 1 in obese subjects
    L Alberti
    A Girola
    L Gilardini
    A Conti
    S Cattaldo
    G Micheletto
    C Invitti
    [J]. International Journal of Obesity, 2007, 31 : 1826 - 1831
  • [4] Type 2 diabetes and metabolic syndrome are associated with increased expression of 11β-hydroxysteroid dehydrogenase 1 in obese subjects
    Alberti, L.
    Girola, A.
    Gilardini, L.
    Conti, A.
    Cattaldo, S.
    Micheletto, G.
    Invitti, C.
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 (12) : 1826 - 1831
  • [5] 11β-hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes
    Stulnig, TM
    Waldhäusl, W
    [J]. DIABETOLOGIA, 2004, 47 (01) : 1 - 11
  • [6] 11β-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes
    T. M. Stulnig
    W. Waldhäusl
    [J]. Diabetologia, 2004, 47 : 1 - 11
  • [7] 11β Hydroxysteroid dehydrogenase – 1 activity in type 2 diabetes mellitus: a comparative study
    Ravindra Shukla
    Asish Kumar Basu
    Biplab Mandal
    Pradip Mukhopadhyay
    Animesh Maity
    Satyam Chakraborty
    Praveen Kumar Devrabhai
    [J]. BMC Endocrine Disorders, 19
  • [8] 11β-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes
    Morgan, Stuart A.
    Tomlinson, Jeremy W.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (09) : 1067 - 1076
  • [9] 11 Hydroxysteroid dehydrogenase-1 activity in type 2 diabetes mellitus: a comparative study
    Shukla, Ravindra
    Basu, Asish Kumar
    Mandal, Biplab
    Mukhopadhyay, Pradip
    Maity, Animesh
    Chakraborty, Satyam
    Devrabhai, Praveen Kumar
    [J]. BMC ENDOCRINE DISORDERS, 2019, 19
  • [10] Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects
    Luisella, Alberti
    Girola, Andrea
    Gilardini, Luisa
    Conti, Antonio
    Micheletto, Giancarlo
    Invitti, Cecilia
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 : S88 - S88
12345